VJOncology is committed to improving our service to you

ASCO 2016 | Global differences in cancer drug prices: a comparative analysis

VJOncology is committed to improving our service to you

Daniel Goldstein

Press brief by Daniel Goldstein, MD of the Rabin Medical Center, Petah Tikva, Israel, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.

Share this video  
Similar topics
Related videos
JAVELIN Renal 101: DepOR & outcomes in RCC
Martin Voss
Genetic risk assessment for hereditary RCC
Michael Daneshvar
Biomarkers in RCC
Martin Voss
Chemo eligibility: bladder cancer
Srikala Sridhar
Kidney cancer: post-surgery follow-up
Suzanne Merrill
Breast Cancer, Gastrointestinal Cancer, Genitourinary Cancer, Gynecological Cancer, Lung Cancer, Skin Cancer
ASCO 2016
Press Brief
3rd June 2016
More from Daniel Goldstein
Is the current dose of pembrolizumab approved for treating lung cancer too high?
Personalized dosing of pembrolizumab has the potential to save $0.8 billion per year
Cancer care: the need for a cost-effective approach
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals